Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis is a progressive lung disease with complex pathophysiology and fatal prognosis. Macrophages (MΦ) contribute to the development of lung fibrosis; however, the underlying mechanisms and specific MΦ subsets involved remain unclear. During lung injury, two subsets of lung MΦ coexist: Siglec-Fhi resident alveolar MΦ and a mixed population of CD11bhi MΦ that primarily mature from immigrating monocytes. Using a novel inducible transgenic system driven by a fragment of the human CD68 promoter, we targeted deletion of the antiapoptotic protein cellular FADD-like IL-1β–converting enzyme–inhibitory protein (c-FLIP) to CD11bhi MΦ. Upon loss of c-FLIP, CD11bhi MΦ became susceptible to cell death. Using this system, we were able to show that eliminating CD11bhi MΦ present 7–14 days after bleomycin injury was sufficient to protect mice from fibrosis. RNA-seq analysis of lung MΦ present during this time showed that CD11bhi MΦ, but not Siglec-Fhi MΦ, expressed high levels of profibrotic chemokines and growth factors. Human MΦ from patients with idiopathic pulmonary fibrosis expressed many of the same profibrotic chemokines identified in murine CD11bhi MΦ. Elimination of monocyte-derived MΦ may help in the treatment of fibrosis. We identify c-FLIP and the associated extrinsic cell death program as a potential pathway through which these profibrotic MΦ may be pharmacologically targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972
Self-citationOrigin and functions of tissue macrophages
Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585
Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S., Deswarte, K., Malissen, B., Hammad, H., & Lambrecht, B. N. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131199 · Cited by 1,276
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Caspases in cell survival, proliferation and differentiation
Lamkanfi, M., Festjens, N., Declercq, W., Berghe, T. V., & Vandenabeele, P. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402047 · Cited by 561
Three Unique Interstitial Macrophages in the Murine Lung at Steady State
Gibbings, S. L., Thomas, S. M., Atif, S. M., McCubbrey, A. L., Desch, A. N., Danhorn, T., Leach, S. M., Bratton, D. L., Henson, P. M., Janssen, W. J., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0361oc · Cited by 482
Self-citationLy6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1719oc · Cited by 466
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis
Larson-Casey, J. L., Deshane, J. S., Ryan, A. J., Thannickal, V. J., & Carter, A. B. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.001 · Cited by 428
Lech, M., & Anders, H.-J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.001 · Cited by 418
Gundra, U. M., Girgis, N. M., Ruckerl, D., Jenkins, S., Ward, L. N., Kurtz, Z. D., Wiens, K. E., Tang, M. S., Basu-Roy, U., Mansukhani, A., et al. (2014) · Blood · doi:10.1182/blood-2013-08-520619 · Cited by 371
c-FLIP, a master anti-apoptotic regulator.
Safa, A. R. (2012) · PubMed · Cited by 346
Janssen, W. J., Barthel, L., Muldrow, A., Oberley-Deegan, R. E., Kearns, M. T., Jakubzick, C., & Henson, P. M. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1891oc · Cited by 345
Self-citationPulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Byrne, A. J., Maher, T. M., & Lloyd, C. M. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.004 · Cited by 315
Identification of Myeloid Cell Subsets in Murine Lungs Using Flow Cytometry
Zaynagetdinov, R., Sherrill, T. P., Kendall, P. L., Segal, B. H., Weller, K. P., Tighe, R. M., & Blackwell, T. S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0366ma · Cited by 251
Gibbings, S. L., Goyal, R., Desch, A. N., Leach, S. M., Prabagar, M., Atif, S. M., Bratton, D. L., Janssen, W., & Jakubzick, C. V. (2015) · Blood · doi:10.1182/blood-2015-01-624809 · Cited by 240
Self-citationCytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
Perlman, H., Pagliari, L. J., Georganas, C., Mano, T., Walsh, K., & Pope, R. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1679 · Cited by 222
Lung environment determines unique phenotype of alveolar macrophages
Guth, A. M., Janssen, W. J., Bosio, C. M., Crouch, E. C., Henson, P. M., & Dow, S. W. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90625.2008 · Cited by 215
Self-citationBaran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
Redente, E. F., Keith, R. C., Janssen, W., Henson, P. M., Ortiz, L. A., Downey, G. P., Bratton, D. L., & Riches, D. W. H. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0386oc · Cited by 195
Self-citationOkuma, T., Terasaki, Y., Kaikita, K., Kobayashi, H., Kuziel, W. A., Kawasuji, M., & Takeya, M. (2004) · The Journal of Pathology · doi:10.1002/path.1667 · Cited by 189
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2
Murray, L. A., Argentieri, R. L., Farrell, F. X., Bracht, M., Sheng, H., Whitaker, B., Beck, H., Tsui, P., Cochlin, K., Evanoff, H. L., et al. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.016 · Cited by 175
RIPK-Dependent Necrosis and Its Regulation by Caspases: A Mystery in Five Acts
Green, D. R., Oberst, A., Dillon, C. P., Weinlich, R., & Salvesen, G. S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.003 · Cited by 171
Bagnoli, M., Canevari, S., & Mezzanzanica, D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.015 · Cited by 170
Downey, G. P., Worthen, G. S., Henson, P. M., & Hyde, D. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.168 · Cited by 161
Self-citationYoon, Y.-S., Kim, S.-Y., Kim, M.-J., Lim, J.-H., Cho, M.-S., & Kang, J. L. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.130 · Cited by 145
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Raghu, G., Martinez, F. J., Brown, K. K., Costabel, U., Cottin, V., Wells, A. U., Lancaster, L., Gibson, K. F., Haddad, T., Agarwal, P., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01558-2014 · Cited by 144
Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions
Öztürk, S., Schleich, K., & Lavrik, I. N. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.019 · Cited by 126
An essential role for c-FLIP in the efficient development of mature T lymphocytes
Zhang, N., & He, Y.-W. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050117 · Cited by 123
Osterholzer, J. J., Olszewski, M. A., Murdock, B. J., Chen, G.-H., Erb-Downward, J. R., Subbotina, N., Browning, K., Lin, Y., Morey, R. E., Dayrit, J. K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200604 · Cited by 116
Regulation of steady-state neutrophil homeostasis by macrophages
Gordy, C., Pua, H., Sempowski, G. D., & He, Y.-W. (2011) · Blood · doi:10.1182/blood-2010-01-265959 · Cited by 110
Quantitative Proteomics of Bronchoalveolar Lavage Fluid in Idiopathic Pulmonary Fibrosis
Foster, M. W., Morrison, L. D., Todd, J. L., Snyder, L. D., Thompson, J. W., Soderblom, E. J., Plonk, K., Weinhold, K. J., Townsend, R., Minnich, A., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501149m · Cited by 108
Mononuclear phagocytes of the intestine, the skin, and the lung
Scott, C. L., Henri, S., & Guilliams, M. (2014) · Immunological Reviews · doi:10.1111/imr.12220 · Cited by 106
The Elusive Antifibrotic Macrophage
Adhyatmika, A., Putri, K. S. S., Beljaars, L., & Melgert, B. N. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00081 · Cited by 75
Isgrò, M., Bianchetti, L., Marini, M. A., Bellini, A., Schmidt, M., & Mattoli, S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.109 · Cited by 72
Ekert, J. E., Murray, L. A., Das, A., Sheng, H., Giles-Komar, J. M., & Rycyzyn, M. A. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-23 · Cited by 71
Weinlich, R., Dillon, C. P., & Green, D. R. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.002 · Cited by 68
Shi, Y., Gochuico, B. R., Yu, G., Tang, X., Osorio, J. C., Fernandez, I. E., Risquez, C. F., Patel, A. S., Shi, Y., Wathelet, M. G., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0434oc · Cited by 59
Kohan, M., Puxeddu, I., Reich, R., Levi‐Schaffer, F., & Berkman, N. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2009.11.003 · Cited by 57
Tománková, T., Kriegová, E., & Liu, M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00203.2014 · Cited by 55
In vivo compartmental analysis of leukocytes in mouse lungs
Patel, B. V., Tatham, K. C., Wilson, M. R., O'Dea, K. P., & Takata, M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00140.2015 · Cited by 49
Frankel, S. K., Moats‐Staats, B. M., Cool, C. D., Wynes, M. W., Stiles, A. D., & Riches, D. W. H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00420.2004 · Cited by 43
Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis
Schwartz, D. A., Helmers, R. A., Dayton, C. S., Merchant, R. K., & Hunninghake, G. W. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.5.1688 · Cited by 43
Cellular FLIP Inhibits Myeloid Cell Activation by Suppressing Selective Innate Signaling
Wu, Y.-J., Wu, Y., Mo, S.-T., Hsiao, H.-W., He, Y.-W., & Lai, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402944 · Cited by 25
McCubbrey, A. L., Barthel, L., Mould, K. J., Mohning, M. P., Redente, E. F., & Janssen, W. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00141.2016 · Cited by 17
Self-citation
Cited by
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
“In that system, we showed that selective genetic deletion of monocytederived alveolar macrophages while leaving tissue-resident alveolar macrophages intact resulted in improved fibrosis, a finding that has been subsequently confirmed by an independent group (35).”
BackgroundResultThe role of macrophages in the resolution of inflammation
Watanabe, S., Alexander, M., Misharin, A. V., & Budinger, G. R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124615 · Cited by 925
“More importantly, in patients with pulmonary fibrosis, single-cell RNA-Seq demonstrated heterogeneity in macrophage phenotypes in patients with fibrosis relative to controls, and spatial transcriptomics confirmed that “profibrotic” macrophages coexist with “normal” macrophages in the same microenvironment, supporting…”
BackgroundProliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Morse, C., Tabib, T., Sembrat, J., Buschur, K. L., Bittar, H. T., Valenzi, E., Jiang, Y., Kass, D. J., Gibson, K., Chen, W., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02441-2018 · Cited by 822
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Biology of lung macrophages in health and disease
Aegerter, H., Lambrecht, B. N., & Jakubzick, C. V. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.010 · Cited by 621
Self-citation
Metadata
- Authors
- McCubbrey, A. L., Barthel, L., Mohning, M. P., Redente, E. F., Mould, K. J., Thomas, S. M., Leach, S. M., Danhorn, T., Gibbings, S. L., Jakubzick, C. V., Henson, P. M., & Janssen, W. J.
- Affiliations
- University of Colorado Anschutz (US)
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and
- National Jewish Health (US)
- Corresponding author
- McCubbrey, Alexandra L.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 66-78
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC5941310
- OpenAlex
- W2750997091
- Cited by
- 195
- References
- 52
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 26 · 2023: 25 · 2022: 24 · 2021: 15 · 2020: 27 · 2019: 15 · 2018: 10
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK2 BX002401)
- National Institutes of Health (T32 HL0070-85, NIH T32, P 30CA046934)
- National Heart, Lung, and Blood Institute (R35HL140039, F32HL131397, F32HL126333, R01HL109517, R01HL114381, R01HL130938, T32HL007085)
- National Cancer Institute (P30CA046934)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- c-FLIP, idiopathic pulmonary fibrosis, bleomycin-induced lung fibrosis, macrophage apoptosis, monocyte-derived macrophages, alveolar macrophages, Siglec-F, chemokines, growth factors, macrophage depletion
- MeSH terms
- Animals, Bleomycin, Female, Humans, Macrophages, Male, Pulmonary Fibrosis, Gene Deletion, CD11 Antigens, Mice, CASP8 and FADD-Like Apoptosis Regulating Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.